Clinical Education Initiative
Events from this organizer
-
-

CME/CNE/CPE | Hep C Treatment (Clinical Education Initiative)
This webinar will review recommended regimens to treat Hep C.
-
-

CME/CNE/CE | Hep B & C: Coinfection & Reactivation (Clinical Education Initiative)
This webinar will discuss about Hep B and C coinfection and reactivation.
-

CME/CNE | Pregnancy & Substance Use Disorder: Shifting from Criminalization to Chronic Disease Management (Clinical Education Initiative)
This webinar will discuss strategies on pregnancy and substance use disorder.
-
-

CME/CNE/CPE | Caring for Pregnant & Postpartum Persons with Opioid Use Disorder (Clinical Education Initiative)
This webinar will discuss strategies on caring for pregnant and postpartum persons with Opioid Use Disorder.
-

Save the Date | 3rd Annual NYS Hep C Elimination Progress Report Virtual Meeting (NYS Health Dept)
Zoom Webinar NYSave-the-Date to the 3rd Annual NYS Hep C Elimination Progress Report Virtual Meeting on May 14, 2025 from 10 AM – 2 PM.
-

CME/CNE/CPE | Hep C Screening & Pre-treatment Evaluation: Point-of-Care RNA Testing (Clinical Education Initiative)
This webinar will discuss Hep C point-of-care RNA testing.
-

CME/CNE/CE | Hep C & Alcohol (Clinical Education Initiative)
This webinar will provide an overview of how alcohol impacts the course of Hep C infection and treatment.
-

CME/CNE/CPE | Hep C Screening & Pre-treatment Evaluation: Opt-Out Testing & Communication Skills (Clinical Education Initiative)
This webinar will discuss opt-out testing and communication skills.
-
-

Save the Date | 25th HIV & Hep C Clinical Care Symposium (AIDs Education & Training Center Program)
Zoom Webinar NYSave-the-Date to the 25th HIV & Hep C Clinical Care Symposium on June 4, 2025 from 8 AM – 4 PM.
-
-

Achieved SVR, What’s Next? Hep C Post-Treatment Outcomes and Management (Clinical Education Initiative)
Achieved SVR, What's Next? Hep C Post-Treatment Outcomes and Management Wednesday, January 7, 2026 | 4:00 PM - 5:00 PM RSVP Description: Objectives: Describe outcomes after SVR, including liver disease course and progression Describe how to manage non-cirrhotic and cirrhotic patients post-SVR Discuss at risk populations for HCV reinfection and patient counseling strategies RSVP






